Table 3.
Malaria chemoprophylaxis in VFR travelers compared with non-VFR travelers traveling to countries that include regions endemic for malaria
| VFR N (%) | Non-VFR N (%) | P value | |
|---|---|---|---|
| Antimalarial (any) | 2,724 (74.7)* | 12,172 (72.0)† | < 0.0001 |
| Atovaquone/proguanil | 1,260 (34.8) | 9,325 (55.6) | |
| Mefloquine | 1,092 (30.2) | 606 (3.6) | |
| Chloroquine | 115 (3.2) | 1,108 (6.6) | |
| Doxycycline | 192 (5.0) | 838 (5.0) | |
| Primaquine | 0 (0) | 5 (< 0.1) |
*
Sixty-five travelers received more than one prescription or could not be classified.
†
Two hundred ninety travelers received more than one prescription or could not be classified.